{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:15:57Z","timestamp":1794266157145,"version":"4.9.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastomas (GBM) are brain tumors with the worst prognosis despite treatment with surgery and radio\/chemotherapy, emphasizing the need for new therapies and improved treatment efficacy. Previously, we showed that clinically relevant ionizing radiation (IR) doses enhance GBM cell dedifferentiation into a stem-like phenotype, increasing stemness markers, self-renewal, and tumorigenic abilities. This work focuses on identifying early mechanisms driving this plasticity, particularly metabolic adaptations, as tumor metabolism may support therapy resistance and recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, primary cell lines were established from GBM biopsies of several patients and cultured either in restrictive medium to form neurospheres (NS) enriched in GBM stem-like cells (GSC) or in normal medium to obtain their differentiated progenies. These differentiated GBM cells were then subjected to a short-term dedifferentiation protocol after IR (24 to 72\u00a0h) to characterize their metabolic and phenotypic properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that early stem marker increases after IR exposure coincide with higher oxygen consumption rate (OCR), mitochondrial ATP production, and extracellular acidification rate (ECAR). However, lactate production remained unchanged, and glucose uptake showed only a transient, nonspecific increase. This shift to oxidative mitochondrial metabolism, coupled with extracellular acidosis, promotes a stem-like phenotype and is associated with Carbonic Anhydrase IX (CA9) overexpression, an extracellular membrane protein producing H\u2009+\u2009to buffer intracellular pH. CA9 downregulation via ShRNA reduces extracellular acidification and blocks early IR-induced dedifferentiation, such as neurosphere (NS) formation and stem marker overexpression. Similarly, increased OCR and ECAR, often linked to CA9 overexpression, are observed in patient-derived GSC compared to their differentiated progenies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight CA9 as a potential target to block IR-induced early dedifferentiation process as well as the specific metabolic state of GSC. Our study strengthens the therapeutic potential of CA9 inhibition to limit GBM-associated acidic extracellular environment and enhance radiotherapy efficiency by limiting tumor cell plasticity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40478-025-02161-2","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:46:50Z","timestamp":1764330410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Early metabolic reprogramming and carbonic anhydrase IX-mediated extracellular acidification drive radiotherapy-induced glioblastoma cell dedifferentiation"],"prefix":"10.1186","volume":"14","author":[{"given":"Perrine","family":"Dahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Maillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Malric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Martinez-Gala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Flandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Aboudaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"H\u00e9li\u00e8s-Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Skuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Monferran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Nicaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Decamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Toulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cohen-Jonathan Moyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lemari\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"2161_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"2161_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"2161_CR3","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg DM, Lhermitte B et al (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318:2306. https:\/\/doi.org\/10.1001\/jama.2017.18718","journal-title":"JAMA"},{"key":"2161_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","volume":"22","author":"RC Gimple","year":"2022","unstructured":"Gimple RC, Yang K, Halbert ME, Agnihotri S, Rich JN (2022) Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat Rev Cancer 22:497\u2013514. https:\/\/doi.org\/10.1038\/s41568-022-00486-x","journal-title":"Nat Rev Cancer"},{"key":"2161_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/cells10030621","volume":"10","author":"K Biserova","year":"2021","unstructured":"Biserova K, Jakovlevs A, Uljanovs R, Strumfa I (2021) Cancer stem cells: significance in origin, pathogenesis and treatment of glioblastoma. Cells 10:621. https:\/\/doi.org\/10.3390\/cells10030621","journal-title":"Cells"},{"key":"2161_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9060057","volume":"9","author":"L Annovazzi","year":"2017","unstructured":"Annovazzi L, Mellai M, Schiffer D (2017) Chemotherapeutic drugs: DNA damage and repair in glioblastoma. Cancers (Basel) 9:57. https:\/\/doi.org\/10.3390\/cancers9060057","journal-title":"Cancers (Basel)"},{"key":"2161_CR7","doi-asserted-by":"publisher","first-page":"7774","DOI":"10.1074\/jbc.RA120.013778","volume":"295","author":"CAA Lee","year":"2020","unstructured":"Lee CAA, Banerjee P, Wilson BJ, Wu S, Guo Q, Berg G et al (2020) Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism. J Biol Chem 295:7774\u20137788. https:\/\/doi.org\/10.1074\/jbc.RA120.013778","journal-title":"J Biol Chem"},{"key":"2161_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2119\/molmed.2010.00062","volume":"17","author":"IV Ulasov","year":"2011","unstructured":"Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS (2011) Inhibition of sonic hedgehog and notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Mol Med 17:103\u2013112. https:\/\/doi.org\/10.2119\/molmed.2010.00062","journal-title":"Mol Med"},{"key":"2161_CR9","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1158\/0008-5472.CAN-11-3760","volume":"72","author":"KM Joo","year":"2012","unstructured":"Joo KM, Jin J, Kim E, Ho Kim K, Kim Y, Gu Kang B et al (2012) MET signaling regulates glioblastoma stem cells. Cancer Res 72:3828\u20133838. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3760","journal-title":"Cancer Res"},{"key":"2161_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.509","volume":"5","author":"P Dahan","year":"2014","unstructured":"Dahan P, Martinez Gala J, Delmas C, Monferran S, Malric L, Zentkowski D et al (2014) Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance. Cell Death Dis 5:e1543. https:\/\/doi.org\/10.1038\/cddis.2014.509","journal-title":"Cell Death Dis"},{"key":"2161_CR11","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","volume":"8","author":"JM Heddleston","year":"2009","unstructured":"Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8:3274\u20133284","journal-title":"Cell Cycle"},{"key":"2161_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.620883","volume":"9","author":"X-Y Gao","year":"2021","unstructured":"Gao X-Y, Zang J, Zheng M-H, Zhang Y-F, Yue K-Y, Cao X-L et al (2021) Temozolomide treatment induces HMGB1 to promote the formation of glioma stem cells via the TLR2\/NEAT1\/Wnt pathway in glioblastoma. Front Cell Dev Biol 9:620883. https:\/\/doi.org\/10.3389\/fcell.2021.620883","journal-title":"Front Cell Dev Biol"},{"key":"2161_CR13","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1158\/1535-7163.MCT-15-0675","volume":"15","author":"G Lee","year":"2016","unstructured":"Lee G, Auffinger B, Guo D, Hasan T, Deheeger M, Tobias AL et al (2016) Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model. Mol Cancer Ther 15:3064\u20133076. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0675","journal-title":"Mol Cancer Ther"},{"key":"2161_CR14","doi-asserted-by":"publisher","first-page":"9951","DOI":"10.1073\/pnas.1016912108","volume":"108","author":"Y Li","year":"2011","unstructured":"Li Y, Li A, Glas M, Lal B, Ying M, Sang Y et al (2011) c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci U S A 108:9951\u20139956","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2161_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-015-0420-3","volume":"14","author":"E Fessler","year":"2015","unstructured":"Fessler E, Borovski T, Medema JP (2015) Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF. Mol Cancer 14:157","journal-title":"Mol Cancer"},{"key":"2161_CR16","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-19-0855","volume":"80","author":"F Almairac","year":"2020","unstructured":"Almairac F, Turchi L, Sakakini N, Debruyne DN, Elkeurti S, Gjernes E et al (2020) ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a \u201cToggle Switch\u201d of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells. Cancer Res 80:3236\u20133250. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0855","journal-title":"Cancer Res"},{"key":"2161_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/cdd.2015.91","volume":"23","author":"O Fornara","year":"2016","unstructured":"Fornara O, Bartek J, Rahbar A, Odeberg J, Khan Z, Peredo I et al (2016) Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact. Cell Death Differ 23:261\u2013269. https:\/\/doi.org\/10.1038\/cdd.2015.91","journal-title":"Cell Death Differ"},{"key":"2161_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41419-019-1956-8","volume":"10","author":"L Zhang","year":"2019","unstructured":"Zhang L, Shi H, Chen H, Gong A, Liu Y, Song L et al (2019) Dedifferentiation process driven by radiotherapy-induced HMGB1\/TLR2\/YAP\/HIF-1\u03b1 signaling enhances pancreatic cancer stemness. Cell Death Dis 10:724. https:\/\/doi.org\/10.1038\/s41419-019-1956-8","journal-title":"Cell Death Dis"},{"key":"2161_CR19","doi-asserted-by":"publisher","first-page":"16105","DOI":"10.1038\/cddiscovery.2016.105","volume":"3","author":"P Wang","year":"2017","unstructured":"Wang P, Wan W, Xiong S-L, Feng H, Wu N (2017) Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discov 3:16105. https:\/\/doi.org\/10.1038\/cddiscovery.2016.105","journal-title":"Cell Death Discov"},{"key":"2161_CR20","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41388-018-0480-0","volume":"38","author":"M Nakano","year":"2019","unstructured":"Nakano M, Kikushige Y, Miyawaki K, Kunisaki Y, Mizuno S, Takenaka K et al (2019) Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer. Oncogene 38:780\u2013793. https:\/\/doi.org\/10.1038\/s41388-018-0480-0","journal-title":"Oncogene"},{"key":"2161_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092511","volume":"12","author":"MY Ali","year":"2020","unstructured":"Ali MY, Oliva CR, Noman ASM, Allen BG, Goswami PC, Zakharia Y et al (2020) Radioresistance in glioblastoma and the development of radiosensitizers. Cancers (Basel) 12:2511. https:\/\/doi.org\/10.3390\/cancers12092511","journal-title":"Cancers (Basel)"},{"key":"2161_CR22","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.18632\/oncotarget.3015","volume":"6","author":"CR Oliva","year":"2015","unstructured":"Oliva CR, Markert T, Gillespie GY, Griguer CE (2015) Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas. Oncotarget 6:4330\u20134344. https:\/\/doi.org\/10.18632\/oncotarget.3015","journal-title":"Oncotarget"},{"key":"2161_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.7150\/ijbs.79928","volume":"19","author":"Y Yu","year":"2023","unstructured":"Yu Y, Yu J, Ge S, Su Y, Fan X (2023) Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy. Int J Biol Sci 19:811\u2013828. https:\/\/doi.org\/10.7150\/ijbs.79928","journal-title":"Int J Biol Sci"},{"key":"2161_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12929-022-00804-3","volume":"29","author":"Y-T Tsai","year":"2022","unstructured":"Tsai Y-T, Lo W-L, Chen P-Y, Ko C-Y, Chuang J-Y, Kao T-J et al (2022) Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation. J Biomed Sci 29:21. https:\/\/doi.org\/10.1186\/s12929-022-00804-3","journal-title":"J Biomed Sci"},{"key":"2161_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121046","volume":"10","author":"C-L Lu","year":"2015","unstructured":"Lu C-L, Qin L, Liu H-C, Candas D, Fan M, Li JJ (2015) Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition - a Warburg-reversing effect. PLoS ONE 10:e0121046. https:\/\/doi.org\/10.1371\/journal.pone.0121046","journal-title":"PLoS ONE"},{"key":"2161_CR26","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-15-0247","author":"H Shen","year":"2015","unstructured":"Shen H, Hau E, Joshi S, Dilda PJ, McDonald KL (2015) Sensitization of glioblastoma cells to irradiation by modulating the glucose metabolism. Mol Cancer Ther. https:\/\/doi.org\/10.1158\/1535-7163.mct-15-0247","journal-title":"Mol Cancer Ther"},{"key":"2161_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123721","volume":"10","author":"J Sesen","year":"2015","unstructured":"Sesen J, Dahan P, Scotland SJ, Saland E, Dang VT, Lemarie A et al (2015) Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. PLoS ONE 10:e0123721. https:\/\/doi.org\/10.1371\/journal.pone.0123721","journal-title":"PLoS ONE"},{"key":"2161_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080397","volume":"8","author":"F Ye","year":"2013","unstructured":"Ye F, Zhang Y, Liu Y, Yamada K, Tso JL, Menjivar JC et al (2013) Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. PLoS ONE 8:e80397. https:\/\/doi.org\/10.1371\/journal.pone.0080397","journal-title":"PLoS ONE"},{"key":"2161_CR29","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/ncb3272","volume":"17","author":"S Tardito","year":"2015","unstructured":"Tardito S, Oudin A, Ahmed SU, Fack F, Keunen O, Zheng L et al (2015) Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat Cell Biol 17:1556\u20131568. https:\/\/doi.org\/10.1038\/ncb3272","journal-title":"Nat Cell Biol"},{"key":"2161_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/neuonc\/now128","volume":"19","author":"H Lin","year":"2017","unstructured":"Lin H, Patel S, Affleck VS, Wilson I, Turnbull DM, Joshi AR et al (2017) Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells. Neuro-oncol 19:43\u201354. https:\/\/doi.org\/10.1093\/neuonc\/now128","journal-title":"Neuro-oncol"},{"key":"2161_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fonc.2019.00118","volume":"9","author":"D Garnier","year":"2019","unstructured":"Garnier D, Renoult O, Alves-Guerra MC, Paris F, Pecqueur C (2019) Glioblastoma stem-like cells, metabolic strategy to kill a challenging target. Front Oncol 9:118. https:\/\/doi.org\/10.3389\/fonc.2019.00118","journal-title":"Front Oncol"},{"key":"2161_CR32","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.188292.112","volume":"26","author":"M Janiszewska","year":"2012","unstructured":"Janiszewska M, Suva ML, Riggi N, Houtkooper RH, Auwerx J, Clement-Schatlo V et al (2012) Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev 26:1926\u20131944","journal-title":"Genes Dev"},{"key":"2161_CR33","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/febs.15187","volume":"287","author":"K Kuramoto","year":"2020","unstructured":"Kuramoto K, Yamamoto M, Suzuki S, Sanomachi T, Togashi K, Seino S et al (2020) Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells. FEBS J 287:2023\u20132036. https:\/\/doi.org\/10.1111\/febs.15187","journal-title":"FEBS J"},{"key":"2161_CR34","doi-asserted-by":"publisher","first-page":"16062","DOI":"10.1073\/pnas.1106704108","volume":"108","author":"E Vlashi","year":"2011","unstructured":"Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M et al (2011) Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A 108:16062\u201316067","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2161_CR35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3579","volume":"13","author":"SK Parks","year":"2013","unstructured":"Parks SK, Chiche J, Pouyssegur J (2013) Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 13:611\u2013623","journal-title":"Nat Rev Cancer"},{"key":"2161_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer E, Pedersen SF (2020) The acidic tumor microenvironment as a driver of cancer. Annu Rev Physiol 82:103\u2013126. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034627","journal-title":"Annu Rev Physiol"},{"key":"2161_CR37","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1158\/1078-0432.ccr-11-1877","volume":"18","author":"A McIntyre","year":"2012","unstructured":"McIntyre A, Patiar S, Wigfield S, Li J, Ledaki I, Turley H et al (2012) Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy. Clin Cancer Res 18:3100\u20133111. https:\/\/doi.org\/10.1158\/1078-0432.ccr-11-1877","journal-title":"Clin Cancer Res"},{"key":"2161_CR38","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/cncr.10767","volume":"95","author":"M Reichert","year":"2002","unstructured":"Reichert M, Steinbach JP, Supra P, Weller M (2002) Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis. Cancer 95:1113\u20131119. https:\/\/doi.org\/10.1002\/cncr.10767","journal-title":"Cancer"},{"key":"2161_CR39","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/0008-5472.can-12-2796","volume":"73","author":"V Estrella","year":"2013","unstructured":"Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A et al (2013) Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 73:1524\u20131535. https:\/\/doi.org\/10.1158\/0008-5472.can-12-2796","journal-title":"Cancer Res"},{"key":"2161_CR40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/cdd.2010.150","volume":"18","author":"AB Hjelmeland","year":"2011","unstructured":"Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, MacSwords J, Lathia JD et al (2011) Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ 18:829\u2013840","journal-title":"Cell Death Differ"},{"key":"2161_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-018-1242-1","volume":"10","author":"P Hu","year":"2019","unstructured":"Hu P, Li S, Tian N, Wu F, Hu Y, Li D et al (2019) Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D. Cell Death Dis 10:25. https:\/\/doi.org\/10.1038\/s41419-018-1242-1","journal-title":"Cell Death Dis"},{"key":"2161_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi0114","volume":"9","author":"A Lemari\u00e9","year":"2023","unstructured":"Lemari\u00e9 A, Lubrano V, Delmas C, Lusque A, Cerapio J-P, Perrier M et al (2023) The STEMRI trial: magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells. Sci Adv 9:eadi0114. https:\/\/doi.org\/10.1126\/sciadv.adi0114","journal-title":"Sci Adv"},{"key":"2161_CR43","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3390\/cancers14112803","volume":"14","author":"T Duval","year":"2022","unstructured":"Duval T, Lotterie J-A, Lemarie A, Delmas C, Tensaouti F, Moyal EC-J et al (2022) Glioblastoma stem-like cell detection using perfusion and diffusion MRI. Cancers 14:2803. https:\/\/doi.org\/10.3390\/cancers14112803","journal-title":"Cancers"},{"key":"2161_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.taap.2014.07.025","volume":"280","author":"C Helies-Toussaint","year":"2014","unstructured":"Helies-Toussaint C, Peyre L, Costanzo C, Chagnon MC, Rahmani R (2014) Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol Appl Pharmacol 280:224\u2013235","journal-title":"Toxicol Appl Pharmacol"},{"key":"2161_CR45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/1541-7786.MCR-18-0386","volume":"17","author":"L Malric","year":"2019","unstructured":"Malric L, Monferran S, Delmas C, Arnauduc F, Dahan P, Boyrie S et al (2019) Inhibiting integrin \u03b28 to differentiate and radiosensitize glioblastoma-initiating cells. Mol Cancer Res 17:384\u2013397. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0386","journal-title":"Mol Cancer Res"},{"key":"2161_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","volume":"157","author":"ML Suva","year":"2014","unstructured":"Suva ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD et al (2014) Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157:580\u2013594. https:\/\/doi.org\/10.1016\/j.cell.2014.02.030","journal-title":"Cell"},{"key":"2161_CR47","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47\u2013e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"issue":"42\u201356","key":"2161_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L et al (2017) Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 32(42\u201356):e6. https:\/\/doi.org\/10.1016\/j.ccell.2017.06.003","journal-title":"Cancer Cell"},{"key":"2161_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/neuonc\/now247","volume":"19","author":"RL Bowman","year":"2017","unstructured":"Bowman RL, Wang Q, Carro A, Verhaak RGW, Squatrito M (2017) GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro Oncol 19:139\u2013141. https:\/\/doi.org\/10.1093\/neuonc\/now247","journal-title":"Neuro Oncol"},{"key":"2161_CR50","doi-asserted-by":"publisher","first-page":"33788","DOI":"10.18632\/oncotarget.26082","volume":"9","author":"S Boyrie","year":"2018","unstructured":"Boyrie S, Delmas C, Lemarie A, Lubrano V, Dahan P, Malric L et al (2018) RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma. Oncotarget 9:33788\u201333803. https:\/\/doi.org\/10.18632\/oncotarget.26082","journal-title":"Oncotarget"},{"key":"2161_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cancers16010027","volume":"16","author":"A Bentaberry-Rosa","year":"2023","unstructured":"Bentaberry-Rosa A, Nicaise Y, Delmas C, Gouaz\u00e9-Andersson V, Cohen-Jonathan-Moyal E, Seva C (2023) Overexpression of growth differentiation factor 15 in glioblastoma stem cells promotes their radioresistance. Cancers (Basel) 16:27. https:\/\/doi.org\/10.3390\/cancers16010027","journal-title":"Cancers (Basel)"},{"key":"2161_CR52","doi-asserted-by":"publisher","first-page":"9137","DOI":"10.3390\/ijms24119137","volume":"24","author":"C Bernhard","year":"2023","unstructured":"Bernhard C, Reita D, Martin S, Entz-Werle N, Dontenwill M (2023) Glioblastoma metabolism: insights and therapeutic strategies. IJMS 24:9137. https:\/\/doi.org\/10.3390\/ijms24119137","journal-title":"IJMS"},{"key":"2161_CR53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.drudis.2007.12.008","volume":"13","author":"DA Ferrick","year":"2008","unstructured":"Ferrick DA, Neilson A, Beeson C (2008) Advances in measuring cellular bioenergetics using extracellular flux. Drug Discovery Today 13:268\u2013274","journal-title":"Drug Discovery Today"},{"key":"2161_CR54","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.3390\/ijms22063171","volume":"22","author":"HM Becker","year":"2021","unstructured":"Becker HM, Deitmer JW (2021) Proton transport in cancer cells: the role of carbonic anhydrases. IJMS 22:3171. https:\/\/doi.org\/10.3390\/ijms22063171","journal-title":"IJMS"},{"key":"2161_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/neup.12485","volume":"38","author":"B Cetin","year":"2018","unstructured":"Cetin B, Gonul II, Gumusay O, Bilgetekin I, Algin E, Ozet A et al (2018) Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme. Neuropathology 38:457\u2013462. https:\/\/doi.org\/10.1111\/neup.12485","journal-title":"Neuropathology"},{"key":"2161_CR56","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/neuonc\/nos216","volume":"14","author":"MA Proescholdt","year":"2012","unstructured":"Proescholdt MA, Merrill MJ, Stoerr EM, Lohmeier A, Pohl F, Brawanski A (2012) Function of carbonic anhydrase IX in glioblastoma multiforme. Neuro Oncol 14:1357\u20131366","journal-title":"Neuro Oncol"},{"key":"2161_CR57","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92928","author":"NH Boyd","year":"2017","unstructured":"Boyd NH, Walker K, Fried J, Hackney JR, McDonald PC, Benavides GA et al (2017) Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.92928","journal-title":"JCI Insight"},{"key":"2161_CR58","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1038\/onc.2012.550","volume":"32","author":"FE Lock","year":"2013","unstructured":"Lock FE, McDonald PC, Lou Y, Serrano I, Chafe SC, Ostlund C et al (2013) Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene 32:5210\u20135219","journal-title":"Oncogene"},{"key":"2161_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.905768","volume":"13","author":"N Tatari","year":"2022","unstructured":"Tatari N, Zhang X, Chafe SC, McKenna D, Lawson KA, Subapanditha M et al (2022) Dual antigen T cell engagers targeting CA9 as an effective immunotherapeutic modality for targeting CA9 in solid tumors. Front Immunol 13:905768. https:\/\/doi.org\/10.3389\/fimmu.2022.905768","journal-title":"Front Immunol"},{"key":"2161_CR60","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","volume":"122","author":"HM Becker","year":"2020","unstructured":"Becker HM (2020) Carbonic anhydrase IX and acid transport in cancer. Br J Cancer 122:157\u2013167. https:\/\/doi.org\/10.1038\/s41416-019-0642-z","journal-title":"Br J Cancer"},{"key":"2161_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/cai2.59","volume":"2","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li S, Peng Y, Ma W, Wang Y, Li W (2023) Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma. Cancer Innovation 2:114\u2013130. https:\/\/doi.org\/10.1002\/cai2.59","journal-title":"Cancer Innovation"},{"key":"2161_CR62","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1038\/ncomms7289","volume":"6","author":"KC Kondapalli","year":"2015","unstructured":"Kondapalli KC, Llongueras JP, Capilla-Gonzalez V, Prasad H, Hack A, Smith C et al (2015) A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma. Nat Commun 6:6289","journal-title":"Nat Commun"},{"key":"2161_CR63","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1038\/onc.2013.390","volume":"33","author":"KS Lim","year":"2013","unstructured":"Lim KS, Lim KJ, Price AC, Orr BA, Eberhart CG, Bar EE (2013) Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner. Oncogene 33:4433\u20134441","journal-title":"Oncogene"},{"key":"2161_CR64","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10549-014-3051-2","volume":"146","author":"E Vlashi","year":"2014","unstructured":"Vlashi E, Lagadec C, Vergnes L, Reue K, Frohnen P, Chan M et al (2014) Metabolic differences in breast cancer stem cells and differentiated progeny. Breast Cancer Res Treat 146:525\u2013534. https:\/\/doi.org\/10.1007\/s10549-014-3051-2","journal-title":"Breast Cancer Res Treat"},{"key":"2161_CR65","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1172\/JCI78239","volume":"125","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Sasayama T, Irino Y, Takata K, Nagashima H, Satoh N et al (2015) Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J Clin Invest 125:1591\u20131602","journal-title":"J Clin Invest"},{"key":"2161_CR66","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202115343","volume":"14","author":"J Guyon","year":"2022","unstructured":"Guyon J, Fernandez-Moncada I, Larrieu CM, Bouchez CL, Pagano Zottola AC, Galvis J et al (2022) Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis. EMBO Mol Med 14:e15343. https:\/\/doi.org\/10.15252\/emmm.202115343","journal-title":"EMBO Mol Med"},{"key":"2161_CR67","first-page":"1284","volume":"8","author":"G Helmlinger","year":"2002","unstructured":"Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK (2002) Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res 8:1284\u20131291","journal-title":"Clin Cancer Res"},{"key":"2161_CR68","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/bjc.1998.289","volume":"77","author":"M Yamagata","year":"1998","unstructured":"Yamagata M, Hasuda K, Stamato T, Tannock IF (1998) The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br J Cancer 77:1726\u20131731","journal-title":"Br J Cancer"},{"key":"2161_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbaexp.2005.03.003","volume":"1729","author":"J Kopacek","year":"2005","unstructured":"Kopacek J, Barathova M, Dequiedt F, Sepelakova J, Kettmann R, Pastorek J et al (2005) Mapk pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX. Biochim Biophys Acta 1729:41\u201349. https:\/\/doi.org\/10.1016\/j.bbaexp.2005.03.003","journal-title":"Biochim Biophys Acta"},{"key":"2161_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032581","volume":"24","author":"ES B\u00e1don","year":"2023","unstructured":"B\u00e1don ES, Beke L, Mok\u00e1nszki A, Andr\u00e1s C, M\u00e9hes G (2023) Carbonic anhydrase IX expression and treatment response measured in rectal adenocarcinoma following neoadjuvant chemo-radiotherapy. Int J Mol Sci 24:2581. https:\/\/doi.org\/10.3390\/ijms24032581","journal-title":"Int J Mol Sci"},{"key":"2161_CR71","doi-asserted-by":"publisher","unstructured":"Doyen J, Parks SK, Marci\u00e9 S, Pouyss\u00e9gur J, Chiche J. Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis. Front Oncol. 2013;2. https:\/\/doi.org\/10.3389\/fonc.2012.00199","DOI":"10.3389\/fonc.2012.00199"},{"key":"2161_CR72","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1080\/09553002.2023.2235433","volume":"99","author":"W Huang","year":"2023","unstructured":"Huang W, He Y, Yang S, Xue X, Qin H, Sun T et al (2023) CA9 knockdown enhanced ionizing radiation-induced ferroptosis and radiosensitivity of hypoxic glioma cells. Int J Radiat Biol 99:1908\u20131924. https:\/\/doi.org\/10.1080\/09553002.2023.2235433","journal-title":"Int J Radiat Biol"},{"key":"2161_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejpb.2016.09.018","volume":"109","author":"A Amiri","year":"2016","unstructured":"Amiri A, Le PU, Moquin A, Machkalyan G, Petrecca K, Gillard JW et al (2016) Inhibition of carbonic anhydrase IX in glioblastoma multiforme. European J Pharmaceutics Biopharmaceutic 109:81\u201392. https:\/\/doi.org\/10.1016\/j.ejpb.2016.09.018","journal-title":"European J Pharmaceutics Biopharmaceutic"},{"key":"2161_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100738","volume":"9","author":"N Lynam-Lennon","year":"2014","unstructured":"Lynam-Lennon N, Maher SG, Maguire A, Phelan J, Muldoon C, Reynolds JV et al (2014) Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma. PLoS ONE 9:e100738","journal-title":"PLoS ONE"},{"key":"2161_CR75","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2012.04.033","volume":"53","author":"T Yamamori","year":"2012","unstructured":"Yamamori T, Yasui H, Yamazumi M, Wada Y, Nakamura Y, Nakamura H et al (2012) Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. Free Radical Biol Med 53:260\u2013270","journal-title":"Free Radical Biol Med"},{"key":"2161_CR76","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1038\/onc.2011.167","volume":"30","author":"A Lemarie","year":"2011","unstructured":"Lemarie A, Grimm S (2011) Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer? Oncogene 30:3985\u20134003","journal-title":"Oncogene"},{"key":"2161_CR77","doi-asserted-by":"publisher","first-page":"ra80","DOI":"10.1126\/scisignal.aab1624","volume":"8","author":"DB Rivadeneira","year":"2015","unstructured":"Rivadeneira DB, Caino MC, Seo JH, Angelin A, Wallace DC, Languino LR et al (2015) Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion. Sci Signaling. 8:ra80. https:\/\/doi.org\/10.1126\/scisignal.aab1624","journal-title":"Sci Signaling."},{"key":"2161_CR78","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","volume":"1807","author":"LS Pike","year":"2011","unstructured":"Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M (2011) Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochimica et Biophysica Acta (BBA) 1807:726\u2013734","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"2161_CR79","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1002\/stem.2042","volume":"33","author":"EA Stoll","year":"2015","unstructured":"Stoll EA, Makin R, Sweet IR, Trevelyan AJ, Miwa S, Horner PJ et al (2015) Neural stem cells in the adult subventricular zone oxidize fatty acids to produce energy and support neurogenic activity. Stem Cells 33:2306\u20132319. https:\/\/doi.org\/10.1002\/stem.2042","journal-title":"Stem Cells"},{"key":"2161_CR80","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41419-023-05813-0","volume":"14","author":"C Duman","year":"2023","unstructured":"Duman C, Di Marco B, Nevedomskaya E, Ulug B, Lesche R, Christian S et al (2023) Targeting fatty acid oxidation via Acyl-CoA binding protein hinders glioblastoma invasion. Cell Death Dis 14:296. https:\/\/doi.org\/10.1038\/s41419-023-05813-0","journal-title":"Cell Death Dis"},{"key":"2161_CR81","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41467-022-29137-3","volume":"13","author":"N Jiang","year":"2022","unstructured":"Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y et al (2022) Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun 13:1511. https:\/\/doi.org\/10.1038\/s41467-022-29137-3","journal-title":"Nat Commun"},{"key":"2161_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109916","volume":"9","author":"LS Pike Winer","year":"2014","unstructured":"Pike Winer LS, Wu M (2014) Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate. PLoS ONE 9:e109916","journal-title":"PLoS ONE"},{"key":"2161_CR83","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1158\/0008-5472.CAN-14-0705","volume":"74","author":"C Corbet","year":"2014","unstructured":"Corbet C, Draoui N, Polet F, Pinto A, Drozak X, Riant O et al (2014) The SIRT1\/HIF2alpha axis drives reductive glutamine metabolism under chronic acidosis and alters tumor response to therapy. Cancer Res 74:5507\u20135519","journal-title":"Cancer Res"},{"key":"2161_CR84","doi-asserted-by":"publisher","first-page":"1345522","DOI":"10.3389\/fphar.2024.1345522","volume":"15","author":"Y Fan","year":"2024","unstructured":"Fan Y, Xue H, Li Z, Huo M, Gao H, Guan X (2024) Exploiting the Achilles\u2019 heel of cancer: disrupting glutamine metabolism for effective cancer treatment. Front Pharmacol 15:1345522. https:\/\/doi.org\/10.3389\/fphar.2024.1345522","journal-title":"Front Pharmacol"},{"key":"2161_CR85","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature13981","volume":"518","author":"BW Carey","year":"2015","unstructured":"Carey BW, Finley LWS, Cross JR, Allis CD, Thompson CB (2015) Intracellular [agr]-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518:413\u2013416. https:\/\/doi.org\/10.1038\/nature13981","journal-title":"Nature"},{"issue":"1","key":"2161_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2019.100008","volume":"1","author":"A Linkous","year":"2020","unstructured":"Linkous A, Fine HA (2020) Generating patient-derived gliomas within cerebral organoids. STAR Protoc 1(1):100008. https:\/\/doi.org\/10.1016\/j.xpro.2019.100008","journal-title":"STAR Protoc"},{"key":"2161_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189120","volume":"1879","author":"R Ronca","year":"2024","unstructured":"Ronca R, Supuran CT (2024) Carbonic anhydrase IX: an atypical target for innovative therapies in cancer. Biochimica et Biophysica Acta (BBA) - Rev on Cancer 1879:189120. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189120","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev on Cancer"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02161-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02161-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02161-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:04:03Z","timestamp":1781618643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02161-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2161"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02161-2","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The samples were all obtained after written-informed consent from patients admitted to the Neurosurgery Department at Toulouse University Hospital and processed in accordance with the Institution's Human research Ethics Committee. As mentioned, three samples were notably derived from the STEMRI clinical trial (NCT01872221), which was reviewed and approved by the institutional review board, the French ethics committee on 30 May 2012 (registration number 2012-A00585-38), and the French Drug Administration (ANSM) on 15 June 2012 (registration number B120639-40).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests in relation to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}